Key Role of Recompensation in Systemic Therapy for Hepatocellular Carcinoma

Patrick Twohig¹, Wei-Fan Hsu^{2

3}, Nida Ansari⁴

Affiliations

¹ Division of Gastroenterology and Hepatology, University of Rochester Medical Center, Rochester, New York, USA.
² Department of Internal Medicine, Center for Digestive Medicine, China Medical University Hospital, Taichung, Taiwan.
³ School of Chinese Medicine, China Medical University, Taichung, Taiwan.
⁴ Department of Internal Medicine, St. Joseph's University Medical Center, Paterson, New Jersey, USA.

Editorial

Patrick Twohig et al. Liver Int. 2025 Jun.

. 2025 Jun;45(6):e70141.

doi: 10.1111/liv.70141.

Patrick Twohig¹, Wei-Fan Hsu^{2

3}, Nida Ansari⁴

¹ Division of Gastroenterology and Hepatology, University of Rochester Medical Center, Rochester, New York, USA.
² Department of Internal Medicine, Center for Digestive Medicine, China Medical University Hospital, Taichung, Taiwan.
³ School of Chinese Medicine, China Medical University, Taichung, Taiwan.
⁴ Department of Internal Medicine, St. Joseph's University Medical Center, Paterson, New Jersey, USA.

No abstract available

Keywords: hepatocellular carcinoma; recompensated cirrhosis; systemic therapy.

Publication types